{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:32Z","timestamp":1787020112403,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"DOI":"10.1186\/s12865-024-00647-7","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T11:27:56Z","timestamp":1724326076000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pre-treatment plasma retinol binding protein 4 level and its change after treatments predict systemic treatment response in psoriasis patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Runting","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junge","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"issue":"19","key":"647_CR1","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1001\/jama.2022.5270","volume":"327","author":"K Walter","year":"2022","unstructured":"Walter K, Psoriasis. JAMA. 2022;327(19):1936.","journal-title":"JAMA"},{"key":"647_CR2","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM, Global Psoriasis A. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590.","journal-title":"BMJ"},{"issue":"7","key":"647_CR3","first-page":"CD011535","volume":"7","author":"E Sbidian","year":"2023","unstructured":"Sbidian E, Chaimani A, Guelimi R, Garcia-Doval I, Hua C, Hughes C, Naldi L, Kinberger M, Afach S, Le Cleach L. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev. 2023;7(7):CD011535.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"647_CR4","first-page":"562","volume":"108","author":"KK Garner","year":"2023","unstructured":"Garner KK, Hoy KDS, Carpenter AM. Psoriasis: Recognition and Management Strategies. Am Fam Physician. 2023;108(6):562\u201373.","journal-title":"Am Fam Physician"},{"key":"647_CR5","doi-asserted-by":"crossref","unstructured":"Lee HJ, Kim M. Challenges and Future trends in the treatment of Psoriasis. Int J Mol Sci. 2023;24(17).","DOI":"10.3390\/ijms241713313"},{"issue":"10281","key":"647_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis Lancet. 2021;397(10281):1301\u201315.","journal-title":"Psoriasis Lancet"},{"issue":"3","key":"647_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1001\/jamadermatol.2019.4029","volume":"156","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Puig L, Joshi A, Skup M, Williams D, Li J, Betts KA, Augustin M. Comparison of Biologics and oral treatments for Plaque psoriasis: a Meta-analysis. JAMA Dermatol. 2020;156(3):258\u201369.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"647_CR8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s13555-021-00511-1","volume":"11","author":"AW Armstrong","year":"2021","unstructured":"Armstrong AW, Soliman AM, Betts KA, Wang Y, Gao Y, Puig L, Augustin M. Comparative efficacy and relative ranking of biologics and oral therapies for moderate-to-severe Plaque Psoriasis: A Network Meta-analysis. Dermatol Ther (Heidelb). 2021;11(3):885\u2013905.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"647_CR9","doi-asserted-by":"crossref","unstructured":"Steinhoff JS, Lass A, Schupp M. Retinoid Homeostasis and Beyond: How Retinol Binding Protein 4 Contributes to Health and Disease. Nutrients. 2022; 14(6).","DOI":"10.3390\/nu14061236"},{"issue":"10","key":"647_CR10","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/CM9.0000000000002135","volume":"135","author":"H Huang","year":"2022","unstructured":"Huang H, Xu C. Retinol-binding protein-4 and nonalcoholic fatty liver disease. Chin Med J (Engl). 2022;135(10):1182\u201389.","journal-title":"Chin Med J (Engl)"},{"issue":"22","key":"647_CR11","doi-asserted-by":"publisher","first-page":"7769","DOI":"10.1093\/nar\/11.22.7769","volume":"11","author":"V Colantuoni","year":"1983","unstructured":"Colantuoni V, Romano V, Bensi G, Santoro C, Costanzo F, Raugei G, Cortese R. Cloning and sequencing of a full length cDNA coding for human retinol-binding protein. Nucleic Acids Res. 1983;11(22):7769\u201376.","journal-title":"Nucleic Acids Res"},{"issue":"9\u201310","key":"647_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12012-023-09803-8","volume":"23","author":"C Oluwamodupe","year":"2023","unstructured":"Oluwamodupe C, Adeleye AO. Targeting retinol-binding protein 4 (RBP4) in the management of Cardiometabolic diseases. Cardiovasc Toxicol. 2023;23(9\u201310):285\u201394.","journal-title":"Cardiovasc Toxicol"},{"issue":"49","key":"647_CR13","doi-asserted-by":"publisher","first-page":"31309","DOI":"10.1073\/pnas.2013877117","volume":"117","author":"PM Moraes-Vieira","year":"2020","unstructured":"Moraes-Vieira PM, Yore MM, Sontheimer-Phelps A, Castoldi A, Norseen J, Aryal P, Simonyte Sjodin K, Kahn BB. Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through toll-like receptors 2 and 4. Proc Natl Acad Sci U S A. 2020;117(49):31309\u201318.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"647_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12986-019-0423-y","volume":"17","author":"HM Wang","year":"2020","unstructured":"Wang HM, Wu C, Jiang YY, Wang WM, Jin HZ. Retinol and vitamin A metabolites accumulate through RBP4 and STRA6 changes in a psoriasis murine model. Nutr Metab (Lond). 2020;17:5.","journal-title":"Nutr Metab (Lond)"},{"issue":"2","key":"647_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000351769","volume":"227","author":"AS Karadag","year":"2013","unstructured":"Karadag AS, Ertugrul DT, Kalkan G, Bilgili SG, Celik HT, Takci Z, Balahoroglu R, Calka O. The effect of acitretin treatment on insulin resistance, retinol-binding protein-4, leptin, and adiponectin in psoriasis vulgaris: a noncontrolled study. Dermatology. 2013;227(2):103\u20138.","journal-title":"Dermatology"},{"issue":"2","key":"647_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00403-012-1306-5","volume":"305","author":"J Romani","year":"2013","unstructured":"Romani J, Caixas A, Ceperuelo-Mallafre V, Carrascosa JM, Ribera M, Rigla M, Vendrell J, Luelmo J. Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI. Arch Dermatol Res. 2013;305(2):105\u201312.","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"647_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/09546634.2015.1079300","volume":"27","author":"A Baran","year":"2016","unstructured":"Baran A, Swiderska M, Flisiak I. The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels. J Dermatolog Treat. 2016;27(2):114\u20139.","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"647_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jdv.13005","volume":"30","author":"T Pina","year":"2016","unstructured":"Pina T, Genre F, Lopez-Mejias R, Armesto S, Ubilla B, Mijares V, Dierssen-Sotos T, Corrales A, Gonzalez-Lopez MA, Gonzalez-Vela MC, et al. Anti-TNF-alpha therapy reduces retinol-binding protein 4 serum levels in non-diabetic patients with psoriasis: a 6-month prospective study. J Eur Acad Dermatol Venereol. 2016;30(1):92\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"647_CR19","first-page":"223","volume":"52","author":"Committee on Psoriasis CSoD","year":"2019","unstructured":"Committee on Psoriasis CSoD. Guideline for the diagnosis and treatment of psoriasis in China (2018 simplified edition). Chin J Dermatology. 2019;52(4):223\u201330.","journal-title":"Chin J Dermatology"},{"issue":"3","key":"647_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jaad.2016.11.041","volume":"76","author":"A Blauvelt","year":"2017","unstructured":"Blauvelt A, Papp KA, Griffiths CE, Randazzo B, Wasfi Y, Shen YK, Li S, Kimball AB. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: results from the phase III, double-blinded, placebo- and active comparator-controlled VOYAGE 1 trial. J Am Acad Dermatol. 2017;76(3):405\u201317.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"647_CR21","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1136\/ard-2023-224431","volume":"82","author":"CT Ritchlin","year":"2023","unstructured":"Ritchlin CT, Coates LC, McInnes IB, Mease PJ, Merola JF, Tanaka Y, Asahina A, Gossec L, Gottlieb AB, Warren RB, et al. Bimekizumab treatment in biologic DMARD-naive patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study. Ann Rheum Dis. 2023;82(11):1404\u201314.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"647_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jbspin.2018.07.002","volume":"86","author":"Y Wei","year":"2019","unstructured":"Wei Y, Xia N, Zhang W, Huang J, Ren Z, Zhu L, Zhang Z, Yang L. Serum retinol-binding protein 4 is associated with insulin resistance in patients with early and untreated rheumatoid arthritis. Joint Bone Spine. 2019;86(3):335\u201341.","journal-title":"Joint Bone Spine"},{"issue":"10","key":"647_CR23","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1177\/0961203318778774","volume":"27","author":"DJ Go","year":"2018","unstructured":"Go DJ, Lee JY, Kang MJ, Lee EY, Lee EB, Yi EC, Song YW. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare. Lupus. 2018;27(10):1600\u201315.","journal-title":"Lupus"},{"issue":"2","key":"647_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1684\/ejd.2014.2490","volume":"25","author":"FC Gul","year":"2015","unstructured":"Gul FC, Cicek D, Kaman D, Demir B, Nazik H. Changes of serum lipocalin-2 and retinol binding protein-4 levels in patients with psoriasis and Behcet\u2019s disease. Eur J Dermatol. 2015;25(2):195\u20137.","journal-title":"Eur J Dermatol"},{"issue":"8","key":"647_CR25","first-page":"WL01","volume":"10","author":"OA Bakry","year":"2016","unstructured":"Bakry OA, Shoeib MA, Gayed IM, Menoufy AS. Retinol binding protein 4 in non obese psoriatic cases. J Clin Diagn Res. 2016;10(8):WL01\u20132.","journal-title":"J Clin Diagn Res"},{"issue":"5","key":"647_CR26","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1007\/s11033-021-06420-y","volume":"48","author":"K Gokulakrishnan","year":"2021","unstructured":"Gokulakrishnan K, Pandey GK, Sathishkumar C, Sundararajan S, Durairaj P, Manickam N, Mohan V, Balasubramanyam M. Augmentation of RBP4\/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin. Mol Biol Rep. 2021;48(5):4093\u2013106.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"647_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cmet.2014.01.018","volume":"19","author":"PM Moraes-Vieira","year":"2014","unstructured":"Moraes-Vieira PM, Yore MM, Dwyer PM, Syed I, Aryal P, Kahn BB. RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell Metab. 2014;19(3):512\u201326.","journal-title":"Cell Metab"},{"issue":"10","key":"647_CR28","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1128\/MCB.06193-11","volume":"32","author":"J Norseen","year":"2012","unstructured":"Norseen J, Hosooka T, Hammarstedt A, Yore MM, Kant S, Aryal P, Kiernan UA, Phillips DA, Maruyama H, Kraus BJ, et al. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol Cell Biol. 2012;32(10):2010\u20139.","journal-title":"Mol Cell Biol"},{"issue":"20","key":"647_CR29","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1128\/MCB.00221-13","volume":"33","author":"M Muenzner","year":"2013","unstructured":"Muenzner M, Tuvia N, Deutschmann C, Witte N, Tolkachov A, Valai A, Henze A, Sander LE, Raila J, Schupp M. Retinol-binding protein 4 and its membrane receptor STRA6 control adipogenesis by regulating cellular retinoid homeostasis and retinoic acid receptor alpha activity. Mol Cell Biol. 2013;33(20):4068\u201382.","journal-title":"Mol Cell Biol"},{"key":"647_CR30","doi-asserted-by":"crossref","unstructured":"Flores-Cortez YA, Barragan-Bonilla MI, Mendoza-Bello JM, Gonzalez-Calixto C, Flores-Alfaro E, Espinoza-Rojo M. Interplay of retinol binding protein 4 with obesity and associated chronic alterations (review). Mol Med Rep. 2022;26(1).","DOI":"10.3892\/mmr.2022.12760"},{"key":"647_CR31","doi-asserted-by":"publisher","first-page":"111312","DOI":"10.1016\/j.mce.2021.111312","volume":"531","author":"PA Nono Nankam","year":"2021","unstructured":"Nono Nankam PA, Bluher M. Retinol-binding protein 4 in obesity and metabolic dysfunctions. Mol Cell Endocrinol. 2021;531:111312.","journal-title":"Mol Cell Endocrinol"},{"key":"647_CR32","doi-asserted-by":"crossref","unstructured":"Pazos-Perez A, Pineiro-Ramil M, Franco-Trepat E, Alonso-Perez A, Guillan-Fresco M, Crespo-Golmar A, Lopez-Fagundez M, Aranda JC, Bravo SB, Jorge-Mora A et al. The Hepatokine RBP4 links metabolic diseases to articular inflammation. Antioxid (Basel). 2024;13(1).","DOI":"10.3390\/antiox13010124"},{"key":"647_CR33","doi-asserted-by":"publisher","first-page":"856298","DOI":"10.3389\/fphys.2022.856298","volume":"13","author":"Y Ji","year":"2022","unstructured":"Ji Y, Song J, Su T, Gu X. Adipokine Retinol binding protein 4 and Cardiovascular diseases. Front Physiol. 2022;13:856298.","journal-title":"Front Physiol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-024-00647-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-024-00647-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-024-00647-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T06:35:18Z","timestamp":1724394918000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-024-00647-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1186\/s12865-024-00647-7","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of HanDan Central Hospital. Psoriatic patients and healthy subjects signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}